Abstract
Gastrointestinal stromal tumors (GISTs) are common soft tissue tumors of the gastrointestinal tract and are frequently encountered in surgical practice. The most common location for GISTs is the stomach. Principles of surgical management of resectable GISTs include removal with negative margins and no requirement for regional lymphadenectomy. Both open and minimally invasive surgical approaches have been utilized with noticeable trends toward laparoscopic and robotic techniques. There is little data on the robotic approach; however, small case series have reported favorable results. In fact, robotic techniques may allow surgeons to perform resections in more challenging locations. In this chapter, we describe a step-by-step approach to resection of a large GIST of the proximal stomach near the cardia with subsequent closure of the defect using the robotic platform.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Kindblom LG, Remotti HE, Aldenborg F, et al. Gastrointestinal pacemaker cell tumor (GIPACT): gastrointestinal stromal tumors show phenotypic characteristics of the interstitial cells of Cajal. Am J Pathol. 1998;152(5):1259–69.
Miettinen M, Sarlomo-Rikala M, Lasota J. Gastrointestinal stromal tumors: recent advances in understanding of their biology. Hum Pathol. 1999;30(10):1213–20.
Ma GL, Murphy JD, Martinez ME, et al. Epidemiology of gastrointestinal stromal tumors in the era of histology codes: results of a population-based study. Cancer Epidemiol Biomarkers Prev. 2015;24(1):298–302.
Choi AH, Hamner JB, Merchant SJ, et al. Underreporting of gastrointestinal stromal tumors: is the true incidence being captured? J Gastrointest Surg. 2015;19(9):1699–703.
DeMatteo RP, Lewis JJ, Leung D, et al. Two hundred gastrointestinal stromal tumors: recurrence patterns and prognostic factors for survival. Ann Surg. 2000;231(1):51–8.
Miettinen M, Lasota J. Gastrointestinal stromal tumors: pathology and prognosis at different sites. Semin Diagn Pathol. 2006;23(2):70–83.
Miettinen M, Sobin LH, Lasota J. Gastrointestinal stromal tumors of the stomach: a clinicopathologic, immunohistochemical, and molecular genetic study of 1765 cases with long-term follow-up. Am J Surg Pathol. 2005;29(1):52–68.
Hirota S, Isozaki K, Moriyama Y, et al. Gain-of-function mutations of c-kit in human gastrointestinal stromal tumors. Science. 1998;279(5350):577–80.
Dematteo RP, Ballman KV, Antonescu CR, et al. Adjuvant imatinib mesylate after resection of localised, primary gastrointestinal stromal tumour: a randomised, double-blind, placebo-controlled trial. Lancet. 2009;373(9669):1097–104.
Joensuu H, Eriksson M, Sundby Hall K, et al. One vs three years of adjuvant imatinib for operable gastrointestinal stromal tumor: a randomized trial. JAMA. 2012;307(12):1265–72.
Tokunaga M, Ohyama S, Hiki N, et al. Incidence and prognostic value of lymph node metastasis on c-Kit-positive gastrointestinal stromal tumors of the stomach. Hepato-Gastroenterology. 2011;58(109):1224–8.
De Vogelaere K, Hoorens A, Haentjens P, et al. Laparoscopic versus open resection of gastrointestinal stromal tumors of the stomach. Surg Endosc. 2013;27(5):1546–54.
MacArthur KM, Baumann BC, Nicholl MB. Laparoscopic versus open resection for gastrointestinal stromal tumors (GISTs). J Gastrointest Cancer. 2017;48(1):20–4.
De Vogelaere K, Van Loo I, Peters O, et al. Laparoscopic resection of gastric gastrointestinal stromal tumors (GIST) is safe and effective, irrespective of tumor size. Surg Endosc. 2012;26(8):2339–45.
Lin J, Huang C, Zheng C, et al. Laparoscopic versus open gastric resection for larger than 5 cm primary gastric gastrointestinal stromal tumors (GIST): a size-matched comparison. Surg Endosc. 2014;28(9):2577–83.
Huang CM, Chen QF, Lin JX, et al. Can laparoscopic surgery be applied in gastric gastrointestinal stromal tumors located in unfavorable sites?: a study based on the NCCN guidelines. Medicine. 2017;96(14):e6535.
Vicente E, Quijano Y, Ielpo B, et al. Robot-assisted resection of gastrointestinal stromal tumors (GIST): a single center case series and literature review. Int J Med Rob Compu Assisted Surg. 2016;12(4):718–23.
Buchs NC, Bucher P, Pugin F, et al. Robot-assisted oncologic resection for large gastric gastrointestinal stromal tumor: a preliminary case series. J Laparoendosc Adv Surg Tech A. 2010;20(5):411–5.
Desiderio J, Trastulli S, Cirocchi R, et al. Robotic gastric resection of large gastrointestinal stromal tumors. Int J Surg. 2013;11(2):191–6.
Andtbacka RH, Ng CS, Scaife CL, et al. Surgical resection of gastrointestinal stromal tumors after treatment with imatinib. Ann Surg Oncol. 2007;14(1):14–24.
Eisenberg BL, Harris J, Blanke CD, et al. Phase II trial of neoadjuvant/adjuvant imatinib mesylate (IM) for advanced primary and metastatic/recurrent operable gastrointestinal stromal tumor (GIST): early results of RTOG 0132/ACRIN 6665. J Surg Oncol. 2009;99(1):42–7.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Electronic Supplementary Material
Robotic resection of gastric tumor (MOV 323550 kb)
Rights and permissions
Copyright information
© 2020 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Merchant, S., Pyke, O., Kim, J. (2020). Robotic Segmental Gastrectomy for Large Gastrointestinal Stromal Tumor. In: Kim, J., Garcia-Aguilar, J. (eds) Minimally Invasive Surgical Techniques for Cancers of the Gastrointestinal Tract. Springer, Cham. https://doi.org/10.1007/978-3-030-18740-8_4
Download citation
DOI: https://doi.org/10.1007/978-3-030-18740-8_4
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-18739-2
Online ISBN: 978-3-030-18740-8
eBook Packages: MedicineMedicine (R0)